• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Avanos Medical, Inc. to Webcast Conference Call Discussing Third Quarter 2025 Financial Results

    10/27/25 10:31:00 AM ET
    $AVNS
    Industrial Specialties
    Health Care
    Get the next $AVNS alert in real time by email

    ALPHARETTA, Ga., Oct. 27, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE:AVNS) will webcast its conference call discussing financial results and business highlights for the second quarter 2025 on Wed., Nov. 5, at 9 a.m. ET. The company will issue a news release detailing its results before the market opens that same day.

    (PRNewsfoto/Avanos Medical Inc.)

    The conference call will be hosted by Dave Pacitti, chief executive officer, and Scott Galovan, senior vice president and chief financial officer.

    To instantly join the conference call by phone, use the following link to register close to the call start time: https://emportal.ink/3OBYJOf. After registering, the system will call you and automatically connect you to the conference call. Alternatively, you may join the call by dialing 1-646-357-8785 or 1-800-836-8184 and you will be connected to the call by an operator.

    A simultaneous webcast of the call and the related presentation will be accessible via the Investors section of the Avanos Medical website, https://avanos.investorroom.com/. The replay will be accessible within two hours of the end of the call and will be available for one week. Alternatively, you may dial 1-646-517-4150 or 1-888-660-6345 and enter passcode 21545 #.

    About Avanos Medical, Inc.

    Avanos Medical (NYSE:AVNS) is a medical technology company focused on delivering clinically superior medical device solutions that will help patients get back to the things that matter. Headquartered in Alpharetta, Georgia, Avanos is committed to addressing some of today's most important healthcare needs, including providing a vital lifeline for nutrition to patients from hospital to home, and reducing the use of opioids while helping patients move from surgery to recovery. Avanos develops, manufactures, and markets its recognized brands globally and holds leading market positions in multiple product categories. For more information, visit www.avanos.com and follow Avanos Medical on X (@AvanosMedical), LinkedIn and Facebook.

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/avanos-medical-inc-to-webcast-conference-call-discussing-third-quarter-2025-financial-results-302595410.html

    SOURCE Avanos Medical

    Get the next $AVNS alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AVNS

    DatePrice TargetRatingAnalyst
    7/25/2023Overweight → Sector Weight
    KeyBanc Capital Markets
    5/22/2023$31.00Buy
    CL King
    2/24/2022$47.00 → $41.00Overweight
    Keybanc
    1/7/2022$37.00 → $36.00Underweight
    Morgan Stanley
    8/4/2021$45.00 → $41.00Underweight
    Morgan Stanley
    8/4/2021$60.00 → $45.00Overweight → Equal-Weight
    Stephens
    8/4/2021$55.00 → $47.00Overweight
    Keybanc
    More analyst ratings

    $AVNS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Principal Accounting Officer Hurley John Joseph covered exercise/tax liability with 345 shares, decreasing direct ownership by 3% to 11,364 units (SEC Form 4)

    4 - AVANOS MEDICAL, INC. (0001606498) (Issuer)

    9/9/25 12:55:39 PM ET
    $AVNS
    Industrial Specialties
    Health Care

    New insider Galovan Scott Michael claimed ownership of 111,009 shares (SEC Form 3)

    3 - AVANOS MEDICAL, INC. (0001606498) (Issuer)

    8/22/25 2:40:41 PM ET
    $AVNS
    Industrial Specialties
    Health Care

    Director Blackford Gary bought $659,300 worth of shares (60,000 units at $10.99), increasing direct ownership by 28% to 91,593 units (SEC Form 4)

    4 - AVANOS MEDICAL, INC. (0001606498) (Issuer)

    8/15/25 12:02:50 PM ET
    $AVNS
    Industrial Specialties
    Health Care

    $AVNS
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Blackford Gary bought $659,300 worth of shares (60,000 units at $10.99), increasing direct ownership by 28% to 91,593 units (SEC Form 4)

    4 - AVANOS MEDICAL, INC. (0001606498) (Issuer)

    8/15/25 12:02:50 PM ET
    $AVNS
    Industrial Specialties
    Health Care

    Shimer Julie Ann bought $9,925 worth of shares (500 units at $19.85), increasing direct ownership by 1% to 50,090 units (SEC Form 4)

    4 - AVANOS MEDICAL, INC. (0001606498) (Issuer)

    3/11/24 5:15:37 PM ET
    $AVNS
    Industrial Specialties
    Health Care

    $AVNS
    SEC Filings

    View All

    SEC Form 10-Q filed by Avanos Medical Inc.

    10-Q - AVANOS MEDICAL, INC. (0001606498) (Filer)

    11/5/25 4:28:31 PM ET
    $AVNS
    Industrial Specialties
    Health Care

    Avanos Medical Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - AVANOS MEDICAL, INC. (0001606498) (Filer)

    11/5/25 7:01:10 AM ET
    $AVNS
    Industrial Specialties
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by Avanos Medical Inc.

    SCHEDULE 13G/A - AVANOS MEDICAL, INC. (0001606498) (Subject)

    10/30/25 2:26:35 PM ET
    $AVNS
    Industrial Specialties
    Health Care

    $AVNS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Avanos Medical, Inc. Announces Third Quarter 2025 Results

    Delivered double-digit growth in Specialty Nutrition Systems segmentClosed acquisition of Nexus Medical, providing a complementary technology for the Specialty Nutrition Systems segmentRaising and narrowing top-line guidance and adjusted EPS guidance for the full yearALPHARETTA, Ga., Nov. 5, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE:AVNS) today reported third quarter 2025 financial results. "I am pleased with our third quarter results, both operationally and commercially," said David Pacitti, Avanos' chief executive officer. Pacitti continued, "Avanos delivered double-di

    11/5/25 7:00:00 AM ET
    $AVNS
    Industrial Specialties
    Health Care

    Avanos Medical, Inc. to Webcast Conference Call Discussing Third Quarter 2025 Financial Results

    ALPHARETTA, Ga., Oct. 27, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE:AVNS) will webcast its conference call discussing financial results and business highlights for the second quarter 2025 on Wed., Nov. 5, at 9 a.m. ET. The company will issue a news release detailing its results before the market opens that same day. The conference call will be hosted by Dave Pacitti, chief executive officer, and Scott Galovan, senior vice president and chief financial officer. To instantly join the conference call by phone, use the following link to register close to the call start time:

    10/27/25 10:31:00 AM ET
    $AVNS
    Industrial Specialties
    Health Care

    WRS Group Announces Agreement to Acquire Avanos Medical's US Game Ready® Orthopedic Rental Business

    ANN ARBOR, Mich., Oct. 23, 2025 /PRNewswire/ -- WRS Group, LLC (WRS), a privately held company based in Ann Arbor, Michigan, announced today that it has entered into a definitive agreement with Avanos Medical, Inc. (NYSE:AVNS) to acquire substantially all assets and rights related to Avanos' US Game Ready® orthopedic rental business. WRS Group, a national leader in orthopedic pain management and recovery solutions, specializes in cold and compression therapy for patients recovering from injury or surgery. The acquisition enhances WRS's ability to serve patients, surgeons, and

    10/23/25 8:00:00 AM ET
    $AVNS
    Industrial Specialties
    Health Care

    $AVNS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Avanos Medical downgraded by KeyBanc Capital Markets

    KeyBanc Capital Markets downgraded Avanos Medical from Overweight to Sector Weight

    7/25/23 6:15:12 AM ET
    $AVNS
    Industrial Specialties
    Health Care

    CL King initiated coverage on Avanos Medical with a new price target

    CL King initiated coverage of Avanos Medical with a rating of Buy and set a new price target of $31.00

    5/22/23 8:52:10 AM ET
    $AVNS
    Industrial Specialties
    Health Care

    Keybanc reiterated coverage on Avanos Medical with a new price target

    Keybanc reiterated coverage of Avanos Medical with a rating of Overweight and set a new price target of $41.00 from $47.00 previously

    2/24/22 4:48:01 AM ET
    $AVNS
    Industrial Specialties
    Health Care

    $AVNS
    Financials

    Live finance-specific insights

    View All

    Avanos Medical, Inc. Announces Third Quarter 2025 Results

    Delivered double-digit growth in Specialty Nutrition Systems segmentClosed acquisition of Nexus Medical, providing a complementary technology for the Specialty Nutrition Systems segmentRaising and narrowing top-line guidance and adjusted EPS guidance for the full yearALPHARETTA, Ga., Nov. 5, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE:AVNS) today reported third quarter 2025 financial results. "I am pleased with our third quarter results, both operationally and commercially," said David Pacitti, Avanos' chief executive officer. Pacitti continued, "Avanos delivered double-di

    11/5/25 7:00:00 AM ET
    $AVNS
    Industrial Specialties
    Health Care

    Avanos Medical, Inc. to Webcast Conference Call Discussing Third Quarter 2025 Financial Results

    ALPHARETTA, Ga., Oct. 27, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE:AVNS) will webcast its conference call discussing financial results and business highlights for the second quarter 2025 on Wed., Nov. 5, at 9 a.m. ET. The company will issue a news release detailing its results before the market opens that same day. The conference call will be hosted by Dave Pacitti, chief executive officer, and Scott Galovan, senior vice president and chief financial officer. To instantly join the conference call by phone, use the following link to register close to the call start time:

    10/27/25 10:31:00 AM ET
    $AVNS
    Industrial Specialties
    Health Care

    Avanos Medical Acquires Nexus Medical to Strengthen Nutrition and Medication Delivery in Critical Care

    ALPHARETTA, Ga., Sept. 15, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE:AVNS), a leading medical technology company, today announced the acquisition of Nexus Medical, LLC, a privately held medical device company based in Lenexa, Kansas. Nexus is the maker of the proprietary TKO® anti-reflux needleless connector technology, designed to support safer, more consistent nutrition and medication delivery in high-acuity settings, including Neonatal and Pediatric Intensive Care Units (NICUs and PICUs). The acquisition adds complementary technology to Avanos' Specialty Nutrition Sys

    9/15/25 7:00:00 AM ET
    $AVNS
    Industrial Specialties
    Health Care

    $AVNS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Avanos Medical Inc.

    SC 13G - AVANOS MEDICAL, INC. (0001606498) (Subject)

    11/14/24 1:28:34 PM ET
    $AVNS
    Industrial Specialties
    Health Care

    SEC Form SC 13G/A filed by Avanos Medical Inc. (Amendment)

    SC 13G/A - AVANOS MEDICAL, INC. (0001606498) (Subject)

    2/14/24 11:41:02 AM ET
    $AVNS
    Industrial Specialties
    Health Care

    SEC Form SC 13G/A filed by Avanos Medical Inc. (Amendment)

    SC 13G/A - AVANOS MEDICAL, INC. (0001606498) (Subject)

    2/13/24 4:58:57 PM ET
    $AVNS
    Industrial Specialties
    Health Care

    $AVNS
    Leadership Updates

    Live Leadership Updates

    View All

    Avanos Medical Announces Appointment of Scott Galovan as Senior Vice President, Chief Financial Officer; David Pacitti Appointed to Board of Directors

    ALPHARETTA, Ga., Aug. 5, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE:AVNS), a leading medical technology company, today announced the appointment of Scott Galovan as its new senior vice president, chief financial officer, effective Aug. 1, 2025. Galovan most recently served as Avanos' senior vice president of strategy and corporate development. His background with the company spans 12 years and is highlighted by a proven track record of leading a number of acquisition and divestiture initiatives. Prior to Avanos, he spent 10 years in a variety of strategy, finance, and M&A

    8/5/25 6:45:00 AM ET
    $AVNS
    Industrial Specialties
    Health Care

    Avanos Medical, Inc. Welcomes Camille Chang Gilmore as Senior Vice President and Chief Human Resources Officer

    ALPHARETTA, Ga., June 9, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE:AVNS) a leading medical technology company focused on delivered innovative healthcare solutions, today announced the appointment of Camille Chang Gilmore as senior vice president and chief human resources officer. In this role, Gilmore will lead all aspects of Avanos' people strategy, including talent acquisition and development, workforce planning, leadership development and employee experience. Her arrival reflects the company's continued commitment to building a workplace where every employee feels val

    6/9/25 7:15:00 AM ET
    $AVNS
    Industrial Specialties
    Health Care

    Avanos Medical Announces Appointment of David Pacitti as Chief Executive Officer

    ALPHARETTA, Ga., March 17, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE:AVNS), a leading medical technology company, today announced the appointment of David Pacitti as its new chief executive officer, effective April 14, 2025. Pacitti joins Avanos with a distinguished career in the healthcare sector, most recently serving as president of Siemens Medical Solutions USA, Inc. and Head of the Americas, Siemens Healthineers. In this capacity, he played a pivotal role in driving strategic growth and operational excellence while leading the marketing, sales, service, and support

    3/17/25 7:30:00 AM ET
    $AVNS
    Industrial Specialties
    Health Care